MRI-Based Prediction of Immunotherapy Response in Breast Cancer: A Systematic Review
Background: Immune checkpoint inhibitors (ICIs) have been shown to improve long term outcomes and pathological complete response (pCR) rates in triple-negative breast cancer (TNBC). However, treatment response remains heterogeneous. Magnetic resonance imaging (MRI) has emerged as a promising noninvasive biomarker for p...
Juhi Mehta, Cassidy Adams, Christian Sellers et al.
· Cancers · 0 citations